Historical record - last NADAC effective date: 9/18/2024
Product Information
DICLOFENAC EPOLAMINE 1.3% PTCH is a generic product labeled by YARAL Pharma Inc., priced at $5.6285 per EA under NDC 82347040505. Its NADAC has been published 85 times since Feb 22, 2023.
FDA first approved this application on Jan 31, 2007.
Strength
.013 g/1
Manufacturer
YARAL Pharma Inc.NDC
82347040505
Classification
Generic
Dosage Form
SYSTEM
Route
TOPICAL
Effective Date
9/18/2024
Active Ingredients
DICLOFENAC EPOLAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021234FDA Approved
1/31/2007
On Market Since
11/18/2022
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has been published 85 times since Feb 22, 2023, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6285 per EA |
|---|---|
| All-time high | $5.9957 (Sep 11, 2024) |
| All-time low | $4.6714 (May 22, 2024) |
| Median price | $5.4089 |
| Average price | $5.4517 |
| Largest weekly change | +21.0% (Aug 21, 2024) |
| Weeks tracked | 85 |
| Tracking since | Feb 22, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+8.1%
5Y
N/A
All
+5.2%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diclofenac Epolamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
YARAL Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Epolamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC EPOLAMINE 1.3% PTCH?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC EPOLAMINE 1.3% PTCH, manufactured by YARAL Pharma Inc., is $5.6285 per EA (NDC 82347040505), effective Oct 2, 2024.
How has the price of DICLOFENAC EPOLAMINE 1.3% PTCH changed over time?
Over the history we have for it, the NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has risen 5.2%. It has been tracked across 85 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for DICLOFENAC EPOLAMINE 1.3% PTCH?
Since Feb 22, 2023, the NADAC for DICLOFENAC EPOLAMINE 1.3% PTCH has ranged from a low of $4.6714 (May 22, 2024) to a high of $5.9957 (Sep 11, 2024), with a median of $5.4089 per EA.
Are there cheaper alternatives to DICLOFENAC EPOLAMINE 1.3% PTCH?
No other NADAC-published product currently shares the active ingredient and strength of DICLOFENAC EPOLAMINE 1.3% PTCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DICLOFENAC EPOLAMINE 1.3% PTCH?
DICLOFENAC EPOLAMINE 1.3% PTCH (NDC 82347040505) is labeled by YARAL Pharma Inc., and CMS classifies it as a generic product.